PROCEPT BioRobotics’ cover photo
PROCEPT BioRobotics

PROCEPT BioRobotics

Medical Equipment Manufacturing

San Jose, California 51,125 followers

Aquablation therapy - the BPH treatment of choice for all prostates.

About us

PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics manufactures the AQUABEAM® and HYDROS™ Robotic Systems. The HYDROS Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy. The HYDROS Robotic System is currently cleared for use in the United States only.

Industry
Medical Equipment Manufacturing
Company size
501-1,000 employees
Headquarters
San Jose, California
Type
Public Company
Founded
2009
Specialties
Surgical Robotics, Healthcare, and Manufacturing

Locations

Employees at PROCEPT BioRobotics

Updates

Similar pages

Browse jobs

Funding

PROCEPT BioRobotics 12 total rounds

Last Round

Post IPO secondary

US$ 175.0M

See more info on crunchbase